No. 1 drugmaker Pfizer said Monday it is buying No. 12 Wyeth for $68 billion in a deal that will quickly boost Pfizer’s revenue and profit and transform it overnight into a more diversified company less reliant on its dwindling drug pipeline.
Comment count on this article reflects comments made on Breitbart.com and Facebook. Visit Breitbart's Facebook Page.
Comment count on this article reflects comments made on Breitbart.com and Facebook. Visit Breitbart's Facebook Page.